Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin

D Irish1, I Eltringham, A Teall

  • 1Department of Microbiology, Greenwich Hospital, London, UK.

Insights

A mupirocin-resistant MRSA strain emerged during an epidemic methicillin-resistant Staphylococcus aureus outbreak, complicating control efforts. Alternative treatments were successfully used for eradication.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • An epidemic methicillin-resistant Staphylococcus aureus (EMRSA-3) outbreak occurred in a district hospital in June 1989.
  • The outbreak dynamics were complex, involving inter-hospital and inter-ward patient transfers.
  • Standard control measures included nasal mupirocin application.

Purpose of the Study:

  • To investigate the emergence and characteristics of mupirocin-resistant MRSA (MuMRSA) during an EMRSA-3 outbreak.
  • To understand the genetic basis and transmission of MuMRSA.
  • To evaluate eradication strategies for MuMRSA.

Main Methods:

  • Epidemiological investigation of outbreak dynamics.
  • Molecular typing including phage-typing and pulsed-field gel electrophoresis (PFGE).
  • In vitro plasmid curing experiments and gene probing to identify resistance mechanisms.

Main Results:

  • Mupirocin resistance emerged in MRSA (MuMRSA) during control efforts, likely in a patient with repeated mupirocin exposure.
  • MuMRSA was plasmid-mediated (48 Md plasmid) and spread to 12 patients and 11 staff members.
  • MuMRSA was successfully eradicated using a combination of oral antibiotics (ciprofloxacin, rifampicin), topical treatments (triclosan, fusidic acid, bacitracin).

Conclusions:

  • The emergence of mupirocin resistance poses a significant challenge to MRSA control strategies.
  • Effective multi-drug regimens are crucial for eradicating resistant strains.
  • Alternative topical agents are vital when resistance to primary agents develops.

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...